Skip to main content
Clinical Trials/NL-OMON31940
NL-OMON31940Not yet recruitingNot Applicable

Feasibility of neurocognitive testing in healthy children - Feasibility of neurocognitive testing in healthy children

Centre for Human Drug Research0 sites16 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
16

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
2 to 17 (—)

Inclusion Criteria

  • Age 8-12 years
  • Written informed consent from parents having parental responsibility or from the legal guardian. In the case of a child aged 12 years or older the written informed consent of the child is needed in addition to that of parents having responsibility/legal guardian, in the case of a child aged younger than 12 years, assent needs to be provided.

Exclusion Criteria

  • Any known psychiatric diagnosis (e.g. autism, oppositional defiant disorder, ADHD)
  • Learning disability
  • Significant behavioural problems
  • Use of medication
  • Preterm birth

Investigators

Similar Trials